These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3940623)

  • 21. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
    Prados MD; Scott C; Curran WJ; Nelson DF; Leibel S; Kramer S
    J Clin Oncol; 1999 Nov; 17(11):3389-95. PubMed ID: 10550132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma.
    Ichikawa T; Kurozumi K; Michiue H; Ishida J; Maeda Y; Kondo E; Kawasaki A; Date I
    Clin Neurol Neurosurg; 2014 Dec; 127():106-11. PubMed ID: 25459253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.
    Watne K; Hager B
    J Neurooncol; 1987; 5(1):47-50. PubMed ID: 3598620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.
    Fisher B; Seiferheld W; Schultz C; DeAngelis L; Nelson D; Schold SC; Curran W; Mehta M
    J Neurooncol; 2005 Sep; 74(2):201-5. PubMed ID: 16193393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma. A case report.
    Bremer AM; Nguyen TQ; Balsys R
    J Neurooncol; 1984; 2(1):47-51. PubMed ID: 6470759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution.
    Gaynor ER; Ultmann JE; Golomb HM; Sweet DL
    J Clin Oncol; 1985 Dec; 3(12):1596-604. PubMed ID: 3877790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach.
    de Andrea ML; de Camargo B; Correa Alves A; Machado JC; Franco EL
    Cancer; 1988 Jul; 62(2):240-50. PubMed ID: 3383125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cure in a case of primary hepatic lymphoma.
    Murthy SA; Singh B; Bhalla S; Arora A; Vohra R; Aggarwal S
    Indian J Cancer; 2000 Dec; 37(4):165-72. PubMed ID: 12018569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study.
    Jacot W; Gerlotto-Borne MC; Thezenas S; Pouderoux S; Poujol S; About M; Romieu G
    BMC Cancer; 2010 Jun; 10():257. PubMed ID: 20525352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of treatment of 112 cases of primary CNS lymphoma.
    Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
    Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined intraarterial and systemic chemotherapy for intracerebral tumors.
    Stewart DJ; Grahovac Z; Hugenholtz H; Russell N; Richard M; Benoit B
    Neurosurgery; 1987 Aug; 21(2):207-14. PubMed ID: 2443873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
    Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
    Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary leptomeningeal B-cell lymphoma in a 8-year-old child.
    Hayani A; Venger BH; Rouah E; Laurent JP; Mahoney DH; McClain KL
    Cancer; 1990 Oct; 66(8):1856-60. PubMed ID: 2170000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute signs and symptoms of toxicity due to the BOPP regimen (BCNU, vincristine, procarbazine, cisplatin) during treatment of high-grade astrocytoma].
    Jeremić B; Grujicić D; Jevremović S; Mijatović Lj
    Srp Arh Celok Lek; 1991; 119(9-10):256-8. PubMed ID: 1806994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of M-2 protocol with COP in patients with nodular lymphoma.
    Case DC
    Oncology; 1984; 41(3):159-63. PubMed ID: 6547220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
    Durant JR; Loeb V; Dorfman R; Chan YK
    Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
    Yamanaka R; Shinbo Y; Sano M; Homma J; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Morii K; Onda K; Tanaka R
    Leuk Lymphoma; 2007 Jun; 48(6):1119-26. PubMed ID: 17577775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.